🇦🇺Australia

Prescription Access Scheme Delays

2 verified sources

Definition

Delays in SAS or Authorised Prescriber processes for regulated natural therapies result in unbilled services and capacity loss.

Key Findings

  • Financial Impact: AUD 1,000-5,000 revenue per delayed treatment (2-4 week approval); 5-10 hours admin per application
  • Frequency: Per prescription-only therapy plan
  • Root Cause: Manual handling of TGA portal submissions

Why This Matters

The Pitch: Alternative medicine providers in Australia 🇦🇺 lose AUD 1,000-5,000 per delayed SAS approval on unbilled treatments. Automation streamlines submissions.

Affected Stakeholders

Doctors, Compliance Officers

Deep Analysis (Premium)

Financial Impact

Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.

Unlock to reveal

Current Workarounds

Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.

Unlock to reveal

Get Solutions for This Problem

Full report with actionable solutions

$99$39
  • Solutions for this specific pain
  • Solutions for all 15 industry pains
  • Where to find first clients
  • Pricing & launch costs
Get Solutions Report

Methodology & Sources

Data collected via OSINT from regulatory filings, industry audits, and verified case studies.

Evidence Sources:

Related Business Risks

Informed Consent Non-Compliance Fines

AUD 5,000-50,000 penalty per breach (typical range for professional misconduct); 10-20 hours per audit response

Treatment Plan Rework and Refunds

AUD 500-2,000 per refund (average claim); 2-5% revenue loss from repeat issues

TGA Non-Reporting Penalties

AUD 100,000 to 500,000+ civil penalty per serious breach

AEFI Under-Reporting Costs

2-5% annual revenue loss from recalls and claims; 20-40 hours/month manual reporting burden

State AEFI Reporting Fines

AUD 5,000-20,000 fine per unreported statutory AEFI

Verzögerter Geldeingang bei Selbstzahler-Abonnements

Quantified: ≈ 39 % higher receivables without optimised billing; for AUD 100,000 monthly sales this can mean ≈ AUD 39,000 extra outstanding plus ≈ 1–3 % of annual revenue (AUD 12,000–36,000) in bad‑debt write‑offs.

Request Deep Analysis

🇦🇺 Be first to access this market's intelligence